TRV GP IV, LLC's Form 4 filing
Tango Therapeutics, Inc. (TNGX) · filed Aug 20, 2024
- Accession no.
- 0000950170-24-099253
- Filed
- Aug 20, 2024, 5:59 PM ET
- Trade date
- Aug 16-19, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $2.84M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| TRV GP IV, LLCCIK 0001688325 | 10% Owner |
| Third Rock Ventures GP IV, L.P.CIK 0001688326 | 10% Owner |
| Third Rock Ventures IV, L.P.CIK 0001688327 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 16, 2024 | Common Stock | SSaleDisposed | −135,000 | $9.79 | −$1,321,447.5 | 17,351,475 | Direct | |
| Aug 19, 2024 | Common Stock | SSaleDisposed | −150,000 | $10.09 | −$1,513,920 | 17,201,475 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.